Heme Today Videos

Advertisement
John M. Gansner, MD, PhDHemophilia | July 7, 2025
Dr. John Gansner and Dr. Martina H. Slingsby argue this new agent can provide benefit across all bleeding disorders.
View More
Ulrike Reiss, MDHemophilia | June 30, 2025
Heme Today spoke with Ulrike Reiss, MD, and Andrew Davidoff, MD, of the trial's investigator team.
Caterina P. Minniti, MDSickle Cell Disease | June 25, 2025
Gene therapy is reshaping sickle cell care, raising awareness and advancing treatments beyond the lab.
Paul George, MD, PhDSickle Cell Disease | May 8, 2025
The study led by Paul George, MD, PhD, also highlights the importance of patient regimen adherence to secure these benefits.
Adrián Mosquera Orgueira, MD, PhDMyelofibrosis | April 25, 2025
Adrián Mosquera Orgueira, MD, PhD, spoke of his team's study into machine learning tools for improving risk stratification.
Ivan Maillard, MD, PhDHematology | April 8, 2025
ASH Awards Commitee Chair Ivan Maillard, MD, PhD, and prior awardee Rinku Majumder, PhD, tell of the Grant's positive impact.
Michael DeBaun, MD, MPHSickle Cell Disease | February 18, 2025
An expert panel's review finds SCT has often been misattributed as the direct cause of mortality in patients who have SCT.
Kenneth Adler, MDHematology | February 18, 2025
Organization-level changes at hospitals and medical groups are needed to meaningfully address this longstanding issue.
Belinda Avalos, MDHematology | February 18, 2025
ASH's efforts pertain to professional recruitment as well as to address unique medical issues in patient populations.
Juan Jose Rodriguez-Sevilla, MD, PhDMDS | January 3, 2025
Juan Jose Rodriguez-Sevilla, MD, PhD, summarizes current clinical knowledge about inflammation within MDS pathobiology.
Amy DeZern, MD, MHSMDS | December 6, 2024
Clinicians seek alternatives to biopsy for clinically evaluating bone marrow mutations in cytopenic patients.
Hamda Khan, MASickle Cell Disease | October 25, 2024
A cohort lifetime study from Hamda Khan, MA, and Jason Hodges, PhD, MA, follows patients from pediatric into adult SCD care.
Surbhi Sidana, MDHematology | October 22, 2024
A recent study brings insight regarding the best timing for this CAR-T therapy in patients with prior BCMA-directed therapy.
Theodore Wun, MDSickle Cell Disease | October 22, 2024
Dr. Theodore Wun and Dr. Olubusola Oluwole investigated the causes of rising stroke rates among pediatric and adult patients.
Tamara Diesch-Furlanetto, MDSickle Cell Disease | September 3, 2024
A study has assessed cryogenically preserved ovarian tissue samples from women with SCD for any effects from hydroxyurea.
Soo Park, MDHematology | August 14, 2024
Soo Park, MD, and Zoya Qureshy, MD, explore the mentor-mentee relationship factor in clinicians' professional development.
Nausheen Ahmed, MDHematology | August 2, 2024
In patients who have undergone CAR-T therapy, mortality risk from infection persists longer than from CRS or ICANS.
Steven Romano, MDPolycythemia Vera | July 31, 2024
Initial findings from a phase I study show the compound significantly reduces the need for phlebotomy in patients with PV.
Amer Zeidan, MBBS, MHSMDS | July 26, 2024
MDS experts tell of the clinical factors they consider when selecting from the available agent options.
Amer Zeidan, MBBS, MHSMDS | July 25, 2024
An MDS expert panel discusses findings from the trial's comparison of luspatercept with ESAs in this setting.
Advertisement
Advertisement
Latest News

July 18, 2025